Ki-67 Expression Level in placentas with COVID-19 Infected Women
Abstract
Objective: The SARS-CoV-2 virus, which emerged in December 2019 in Wuhan, China, spread very quickly in a short time and was declared a pandemic by the World Health Organization in March 2020. Physiological and immunological changes during pregnancy cause complications in respiratory tract infections. Complications by COVID-19 lead to a systemic effect that causes maternal and fetal mortality and morbidity. In this study, we aimed to investigate histopathological changes and Ki-67 expression in placentas of women with positive COVID-19 infection.
Study Design: Placentas of 10 samples COVID-19 positive and 10 samples Covid-19 negative pregnant patients who were hospitalized in the Gynecology and Obstetrics Clinic of Dicle University Faculty of Medicine were included in the study. Placental tissues were fixed in 10% formaldehyde (24 hours) and processed for routine paraffin wax tissue staining. Hematoxylin Eosin dye and Ki-67 immunohistochemical staining were performed.
Results: Decidual cell degeneration, increased numbers of syncytial nodes, dilatation in vessels, degenerated villi were observed in the placentas of COVID-19 positive pregnant women. COVID-19 damage regular histology of placental structures. Ki-67 expression was intensely increased in COVID-19 positive placentas compared to COVID-19 negative placentas.
Conclusion: We suggest that COVID-19 causes some abnormalities in the histology of placentas and cell death, which leads to new cell proliferation.
Keywords: COVID-19, placenta, villi, Ki-67, histopathology
Keywords:
COVID19, placenta, villi, Ki-67, histopathologyDOI
https://doi.org/10.22270/jddt.v12i1-S.5324References
Ozdemir O and Pala A. Çocuklarda COVID-19 Enfeksiyonunun Tanısı, Tedavisi ve Korunma Yolları. Journal of Biotechnology and Strategic Health Research. 2020; 4:4 - 21. https://doi.org/10.34084/bshr.711208
Bian XW; COVID-19 Pathology Team . Autopsy of COVID-19 patients in China. Natl Sci Rev. 2020; 7(9):1414-1418. https://doi.org/10.1093/nsr/nwaa123
Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, Zheng M, Yang B, Chen Z. An overview of COVID-19. J Zhejiang Univ Sci B. 2020; 21(5):343-360. https://doi.org/10.1631/jzus.B2000083
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med. 2021; 46:382-391. https://doi.org/10.1016/j.ajem.2020.10.022
Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: What neonatologist need to know. J Med Virol. 2020; 92(6):564-567. https://doi.org/10.1002/jmv.25740
Golden TN, Simmons RA. Maternal and neonatal response to COVID-19. Am J Physiol Endocrinol Metab. 2020; 319(2):E315-E319. https://doi.org/10.1152/ajpendo.00287.2020
Baergen RN, Heller DS. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings. Pediatr Dev Pathol. 2020; 23(3):177-180. https://doi.org/10.1177/1093526620925569
Dong L, Tian J, He S, et al. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020; 323(18):1846-1848. https://doi.org/10.1001/jama.2020.4621
Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Am J Clin Pathol. 2020; 154(1):23-32. https://doi.org/10.1093/ajcp/aqaa089
Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020; 12(2):194. https://doi.org/10.3390/v12020194
Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V, D'Antonio F. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020; 2(2):100107. https://doi.org/10.1016/j.ajogmf.2020.100107
Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A, Gismondo MR, Perotti F, Callegari C, Mancon A, Cammarata S, Beretta I, Nebuloni M, Trabattoni D, Clerici M, Savasi V. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun. 2020; 11(1):5128. https://doi.org/10.1038/s41467-020-18933-4
Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K, Jolly MK, Modi D. Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2. Front Cell Dev Biol. 2020; 8:783. https://doi.org/10.3389/fcell.2020.00783
Oglak S, Obut C. Expression of ADAMTS13 and PCNA in the Placentas of Gestational Diabetic Mothers. International Journal of Morphology. 2021; 39(1):38-44. https://doi.org/10.4067/S0717-95022021000100038
Sun X, Kaufman PD: Ki-67: More than a proliferation marker. Chromosoma 2018; 127(2):175-186 https://doi.org/10.1007/s00412-018-0659-8
Hilali N, Kocarslan S, Vural M, Incebiyik A, Camuzcuoglu A, Camuzcuoglu H. Ki-67 proliferation index in patients with placenta previa percreta in the third trimester. Wien Klin Wochenschr. 2015; 127(3-4):98-102. https://doi.org/10.1007/s00508-014-0634-1
Kaya B, Nayki U, Nayki C, Ulug P, Oner G, Gultekin E, Yildirim Y. Proliferation of trophoblasts and Ki67 expression in preeclampsia. Arch Gynecol Obstet. 2015; 291(5):1041-1046 https://doi.org/10.1007/s00404-014-3538-4
Unek G, Oxmen A, Mendilcioglu I, Simsek M, Korgun ET. The expression of cell cycle related proteins PCNA, Ki67, p27 and p57 in normal and preeclamptic human placentas. Tissue Cell. 2014; 46:198-205 https://doi.org/10.1016/j.tice.2014.04.003
Arnholdt H, Meisel F, Fandrey K, Löhrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchow Archiv B Cell Pathology. 1991; 60(6):365-372 https://doi.org/10.1007/BF02899568
Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta acreta: The role of decidua and extravillous trophoblast. Placenta. 2008; 29(7):639-645 https://doi.org/10.1016/j.placenta.2008.04.008
Published
Abstract Display: 689 
PDF Downloads: 546 PDF Downloads: 76 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.